Runners spend $20 billion annually on running shoes, with many lacing up pairs that can cost as much as $200. But is all this fancy footwear really a good investment? A new musculoskeletal study finds that running with running shoes exerts significantly more stress on key joints than running barefoot, potentially increasing a runner’s risk of developing disabilities such as osteoarthritis in the knees. Continue reading Do Running Shoes Make Us Run the Risk of Injury? Do Running Shoes Make Us Run the Risk of Injury? originally appeared on DailyFinance on Sat, 09 Jan 2010 12:00:00. Filed Under: Healthcare , Berkshire Hathaway Permalink | Tweet this! | Comments

Read more: 
Do Running Shoes Make Us Run the Risk of Injury?

Most people had never heard of clothier Weatherproof Garment until recently when the company posted a billboard in Times Square featuring an AP photo of President Obama wearing one of its jackets as he strolls along the Great Wall of China. The billboard was a huge boost to Weatherproof’s brand, but did little to boost the company’s image with the White House. Continue reading Why Unapproved Obama Ads Are Worth the Risk For Weatherproof, PETA Why Unapproved Obama Ads Are Worth the Risk For Weatherproof, PETA originally appeared on DailyFinance on Sat, 09 Jan 2010 10:00:00. Filed Under: Company News , People , Media Permalink | Tweet this! | Comments

Read the original here: 
Why Unapproved Obama Ads Are Worth the Risk For Weatherproof, PETA

Filed under: Company News , Healthcare , Pfizer , Merck It seems that for Pfizer ( PFE ), the saga of Prempro is just beginning. Barely a month after the world’s largest pharmaceutical company lost a case related to Wyeth’s Prempro hormone replacement therapy drug and was ordered to pay punitive damages on top of earlier compensatory damages, it lost the second pending case in the matter in Philadelphia on Monday. Initially, Pfizer was ordered in September to pay $3.75 million in compensatory damages. The punitive damages amount awarded a month later was sealed pending another verdict in a second similar case in the same courthouse. On Monday, the court revealed that Pfizer has been ordered to pay a total of $103 million in punitive damages in the two cases. The jury found the hormone drugs the two plaintiffs used for years contributed to their breast cancer. Including three other cases, so far Pfizer has been ordered to pay $165 million in punitive damages. Continue reading Prempro lawsuits: Pfizer hit with $103 million more in punitive damages Prempro lawsuits: Pfizer hit with $103 million more in punitive damages originally appeared on DailyFinance on Tue, 24 Nov 2009 18:20:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments

See the rest here:
Prempro lawsuits: Pfizer hit with $103 million more in punitive damages

Filed under: Retirement , Company News , Columns , Economy , People , Investing , Earnings Bears who warn the U.S. stock market has gone too far too fast — the broad Standard & Poor’s 500 index is up 18 percent year to date — may not get much vindication anytime soon. Investors should see stocks continue to rally as long as corporate profits keep recovering, says market expert Joseph Mezrich (pictured), Nomura Securities International’s head of quantitative research. And the signs look good. The estimated earnings growth rate for the Standard & Poor’s 500 during the fourth quarter is 216 percent, according to Thomson Reuters. Even stripping out the volatile financial sector, the other eight out of nine sectors are expected to show a blended growth rate of 7 percent. But that’s still double the 3.5 percent economic growth of the U.S. economy in the third quarter. And Mezrich says it’s the fact that profit growth is outpacing the U.S. economy that stocks have rallied ahead of an economic recovery. Continue reading Nomura’s Joseph Mezrich sees market rally continuing as profits recover Nomura’s Joseph Mezrich sees market rally continuing as profits recover originally appeared on DailyFinance on Fri, 06 Nov 2009 17:00:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments

Go here to read the rest: 
Nomura’s Joseph Mezrich sees market rally continuing as profits recover

Filed under: Kraft Foods In the midst of a hostile takeover bid, Kraft ( KFT ) has set up a series of investor conference calls, which will include its CEO defending its $16.75 billion offer for Cadbury. The fight between the two companies has already gotten ugly. Kraft made the bid last week but Cadbury turned it down, so the American firm has made its offer public, probably to put pressure on the British company’s board. Continue reading Kraft bids for Cadbury and Cadbury says “no” Kraft bids for Cadbury and Cadbury says “no” originally appeared on DailyFinance on Mon, 07 Sep 2009 09:00:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments

See the original post:
Kraft bids for Cadbury and Cadbury says "no"

Filed under: Retirement Retirement mistake #3 is fleeing to safety. We heard a lot from the financial pundits about “fleeing to safety” when the market was tanking. They have been quiet during the recent market rally. For retirees, fleeing to safety can be an oxymoron. Here’s why. By keeping all your investments in Treasury bills, bonds, or even under the mattress, you are preserving your assets and protecting them from the risk of the stock market — but at what cost? Continue reading Retirement mistake no. 3: Fleeing to safety Retirement mistake no. 3: Fleeing to safety originally appeared on DailyFinance on Mon, 07 Sep 2009 10:00:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments

Read more here:
Retirement mistake no. 3: Fleeing to safety